Clinical Trial Update: Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intraductal carboplatin for ductal carcinoma in situ (DCIS) is underway; status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Windy Hill Medical, Inc. | Conditions: Ductal Carcinoma In Situ | Phase 2 | Status: UNKNOWN